Harvard TH Chan School of Public Health
Michael Retsky (PhD in Physics from University of Chicago) made a career change to cancer research thirty years ago. He was on Judah Folkman’s staff at Harvard Medical School for 12 years. Retsky is Editor with Romano Demicheli of a Springer-Nature book published July 2017 (Perioperative Inflammation as Triggering Origin of Metastasis Development). After diagnosis of stage IIIc colon cancer in 1994, he was the first person to use what is now called metronomic chemotherapy. He is a founder and was on the Board of Directors of the Colon Cancer Alliance.
University of Liverpool
DR Jehad Zweiri, lecturer in Cancer studies at the University of Liverpool Medical School, born and grew up in Jordan and received his Bachelor’s degree from the University of Jordan. He obtained his master degree from London School of Hygiene and Tropical Medicine/University of London, and then obtained his PhD degree in 2000 from Kings College Medical School/University of London, in the field of Immune Gene Therapy of Cancer under the supervision of Professor Farzin Farzaneh. He then started his work as Postdoctoral Associate at the department of Immunology and Medicine at the University of Liverpool in 2002. In 2010 he was appointed as a lecturer in the University of Liverpool Medical School and he is currently fellow of the British Higher Education Academy since 2012.
California South University
Prof. Alireza Heidari, Ph.D., D.Sc. is a Full Distinguished Professor and Academic Tenure of Chemistry and also Enrico Fermi Distinguished Chair in Molecular Spectroscopy at California South University (CSU), Irvine, California, USA. He has got his Ph.D. and D.Sc. degrees from California South University (CSU), Irvine, California, USA.. He has participated at more than five hundred reputed international events Also, he possesses many published articles in Science Citation Index (SCI)/International Scientific Indexing (ISI), Medline/PubMed and Scopus Journals.. as research fellow, sabbatical and volunteer researcher or visitor and so on heretofore. He has a history of several years of teaching for college students and various disciplines and trends in different universities. Moreover, he has been a senior advisor in various industry and factories. He is expert in many computer programs and programming languages.
International Institute of Medicine & Science,INC
ALAIN L. FYMAT is a medical-physical scientist and an educator & was educated at the University of Paris-Sorbonne and the University of California at Los Angeles. He is the current President/CEO and Institute Professor at the International Institute of Medicine & Science and Director of the Magnetic Resonance Imaging Center and for a time Acting Chair of Radiology at its Loma Linda, California Medical Center. He has extensively published (~ 445 scholarly publications including patents, books & monographs, book chapters, refereed articles). He is a Board member of several institutions and Health Advisor of the American Heart & Stroke Association (Coachella Valley Division, California). He is Editor-in-Chief & also a member of the New York Academy of Sciences and the European Union Academy of Sciences and a reviewer for the prestigious UNESCO Newton Prize, United Kingdom National Commission for UNESCO.
Dr. Fymat’s current research interests lie at the interface between science and medicine,.
University of Texas
Dr. Shiaw-Yih (Phoebus) Lin is a tenured professor and Deputy Chair of Department of Systems Biology at The University of Texas MD Anderson Cancer Center. Dr. Lin’s research efforts are focused within an overall theme of DNA damage response defects in cancer with the specific emphasis on systems and translational precision cancer therapy. Dr. Lin serves on editorial boards of ten international journals and has served on numerous grant review committees for NIH, DOD and other funding organizations both nationally and internationally.
A.T still University
He received his doctorate in biochemistry from the University of South Dakota of Medicine in 1984. The topic of his research at that time was DNA repair and he isolated and characterized repair mutants in the green algae Chlamydomonas. From there he did post-doctoral work at Mt. Sinai School of Medicine in New York City. The first position was with Dr. David Calhoun working with molecular analysis of E. coli branched-chain amino acid metabolism. The second position was with Dr. Phyllis Shaw, also at Mt. Sinai, involved the molecular and genetic analysis of rat cystatin S structure and expression (Cox et al. 1992). He established his own laboratory in the Department of Biochemistry at A.T. Still University in Kirksville, Missouri in 1991. At this point he directed his interests to melanoma metastasis and has done much work with B16 melanoma cells. He first showed cystatins could block the metastasis of melanoma and has directed his studies around this system (Cox et al. 1999, Ervin et al. 2005). He has received several patents on anti-cancer therapies. He also has research interests in melanoma cell signaling, apoptosis, and natural inhibitors of melanoma.
University of Kentucky
V. K. Cody Bumgardner (PhD in Computer Science from University of Kentucky) spent the first twenty years of his career in IT formerly serving as Director of Enterprise Systems and Development, Chief Technology Architect, and Director of Research Computing. Currently, he serves as Assistant Professor and Chief of the Division of Pathology Informatics in the Department of Pathology and Laboratory Medicine at the University of Kentucky (UK). In addition, he holds a joint appointment in the Department of Computer Science also at UK.
Case Western Reserve University
Dr. Sanjay Gupta is a Professor & Research Director and holds Carter Kissell Endowed Chair in Urologic Oncology in the Department of Urology at Case Western Reserve University and The Urology Institute at the University Hospitals Case Medical Center. He also holds secondary appointments in the Departments of Nutrition and Division of General Medical Sciences at Case Comprehensive Cancer Center. Dr. Gupta has joint appointment as Research Scientist with his research involvement in basic, translational and clinical areas which focus is to identify novel targets to monitor the efficacy of various synthetic and natural agents and develop them as chemo preventatives/therapeutics. His clinical research interests are translation of bench research to its application in clinics. He has authored 150 publications, including book chapters, research articles and reviews, and has spoken at several occasions in cancer prevention symposium, seminars and meetings. He has been serving in various study sections at National Cancer Institute (NCI) and Department of Defense (DOD), and other councils around the globe. He also serves on the Editorial board as well as reviewer for several prestigious scientific journals
University of Debrecen,
Dezso Toth MD, PhD, med. habil. is an Associate Professor in the Department of General Surgery at the University of Debrecen, Hungary. He is a founder member of the County’s Breast Center. He graduated in Medical Economics from University of Debrecen, Medical School. He is certified in General Surgery and Clinical Oncology and he received his Ph.D in Examination of lymph node involvement in solid neoplasms – Sentinel lymph node biopsy“ with summa cum laude. He got habilitation qualification at the University of Debrecen.
He is a board member of the Hungarian Surgical Society and the Hungarian Surgical Endoscopic Section. His research area is in surgical oncology, especially in the field of gastric and breast cancer. He is author and co-author of over 20 peer-reviewed publications (original article, review, chapter and case reports) published in prestigious scientific journals, such as Gastric Cancer, The Breast, Molecular Cancer, Pathology and Oncology Research, World Journal of Surgery and World Journal of Gastrointestinal Oncology. Editorial Board member of International Journal of Cancer and Clinical Research. Editorial Board member of Annals of Breast Cancer Research, The General Surgeon, JSM Clinical and Medical Imaging and The Scientific Pages of Breast Cancer.
Weizmann institute of Science
Dr.Rony Seger studied for a BSc degree in Biology in Ben Gurion University and then moved to the Weizmann Institute for MSc and PhD degrees. Upon completion of his doctorate at the Weizmann Institute of science, Rony joined the group, Nobel Prize Laureate at Washington University, Seattle, as a post doctoral fellow and returned to the Weizmann Institute of Science, as full professor and was the head of the department of Biological Regulation , chair of several institutional centers and the incumbent of the Yale S. Lewine and Ella Miller Lewine professorial chair for cancer research.
Dr. Seger published more than 200 papers in leading journals, supervised more than 70 research students and post-doctoral fellows. He served in the editorial boards. In addition, he is a member of several scientific advisary boards and many Israeli and institutional funding and promotion committees. Dr. Seger organized a large number of scientific conferences, served as a faculty member, and guieded about 80 students and postdocs.
BCNet International Working Group, IARC/WHO
Dr. El Hadji Seydou Mbaye earned his PhD in Biology and Human Pathologies with the collaboration of the International Agency for Research on Cancer and Master of Life and Health, Specialty Biology of microorganisms, Virology, License of Biochemistry in Louis Pasteur University of Strasbourg General Degree in Sciences and Technologies in University of METZ. He has published several books and Editorial member of several international journals.H is lead author of more than 90 peer-reviewed research articles published in reputed journals and member of several associations. Dr. MBAYE has formed for free, more than 250 healthcare professionals for the techniques of cervical cancer screening in Senegal
National Cancer Institute,
Sherry X. Yang is Chief of National Clinical Target Validation Laboratory, Division of Cancer Treatment and Diagnosis at the National Cancer Institute (NCI), Bethesda, Maryland. Dr. Yang joined the NCI in 2001 after completion of her training from the Johns Hopkins Oncology Center. Her research interests include clinical target validation and biomarker science towards precision oncology. Dr. Yang’s laboratory focuses on the predictive and prognostic biomarkers of targeted cancer therapeutics and chemotherapy in breast cancer and lung cancer as well as other cancer types. She is recipient of several biomarkers-related awards and innovations, and an editor of Handbook of Therapeutic Biomarkers in Cancer, 2nd edition
David I Smith received his PhD in Biochemistry from the University of Wisconsin in Madison in 1978. His first academic position was at Wayne State University School of Medicine and in 1996 he moved to the Mayo Clinic as a Professor in the Department of Laboratory Medicine and Pathology. He is also the Chairman of the Technology Assessment Group for the Mayo Clinic Center for Individualized Medicine. His laboratory utilizes next-generation sequencing to study the different ways that human papillomavirus can cause cancer in different tissues. His group also studies the common fragile sites which are regions of profound instability found in all individuals.
University of Coimbra
Álvaro Rocha holds Habilitation in Information Science, PhD in Information Systems and Technologies, MSc in Information Management, and BCs in Computer Science. He is Professor of Information Systems and Software Engineering at University of Coimbra, researcher at CISUC (Centre for Informatics and Systems of the University of Coimbra) and a collaborator researcher at LIACC (Laboratory of Artificial Intelligence and Computer Science) and at CINTESIS (Center for Research in Health Technologies and Information Systems). His main research interests are Information Systems Planning and Management, Maturity Models, Information Systems Quality, Online Service Quality, Intelligent Information Systems, Software Engineering, e-Government, e-Health, and Information Technology in Education.
Professor. Suresh Kumar P. Govind
Professor Dr Suresh Kumar P. Govind is the Consultant and Link Coordinator for the UK funded CICHE link for accreditation of the diagnostic laboratory from the Clinical Pathology Accreditation (CPA) (2001-2010) earned eventually a blue ribband quality from the British Council. The link established Parasites South East Asian Diagnostic Laboratory (Para: SEAD) at the Department of Parasitology, UM which was declared open by the Hon Minister of Health some years back. I am is a member of several professional societies such as the Malaysian Society of Molecular Biology, Institute of Biology, United Kingdom (which carries the title CBiol, MIBiol), Malaysian Scientific Association (which carries the title A.M.S.A), Member, Malaysian Society of Parasitology and Tropical Medicine (MSPTM), Member, Royal Society of Tropical Medicine and Hygiene. He is appointed as member of WHO steering committee. Wrote a detailed manual on the procedures of collecting stools for the detection of parasites for World Bank. Currently teach MBBS, nursing, medical technologists, pharmacy, pathology students, supervise post graduate research students, oversee a diagnostic laboratory and carry out department and faculty administration duties.
Tokyo Institute of Technology
Kenji Suzuki, PhD (by Published Work; Nagoya University) worked at Hitachi Medical Corporation, Japan, Aichi Prefectural University, Japan, as a faculty member. He joined the Department of Radiology, University of Chicago, in 2001, and he was Assistant Professor in the department and Graduate Program in Medical Physics. Since 2014, he has joined the Department of Electric and Computer Engineering and Medical Imaging Research Center, Illinois Institute of Technology, as Associate Professor (Tenured). Since 2017, he has been jointly appointed in World Research Hub Initiative at Tokyo Institute of Technology, Japan, as Full Professor (Specially Appointed). He published more than 320 papers (including 110 peer-reviewed papers in leading journals) in the fields of machine and deep learning, computer-aided diagnosis, and medical image processing and analysis. His papers were cited more than 10,000 times by other researchers. He has an h-index of 44. He is one of the top five most cited researchers in the computer-aided diagnosis field by Google Scholar. He is an inventor on 30 patents (including 13 granted patents), which were licensed to several companies and commercialized. He published 11 books and 22 book chapters and edited 13 journal special issues.
University of Ioannina
Dimitrios H. Roukos, MD, PhD, is Professor of Surgery – Precision Cancer Medicine and Founding director of “Centre for Biosystems and Genome Network Medicine” in the Ioannina University, School of Medicine. Assessing the unmet needs of traditional linear single – gene research, he has shifted to intrapatient comprehensive coding and non-coding genomic and regulatory network heterogeneity in time and space towards the achievement of Precision Cancer Medicine. He has published > 240 PubMed papers, 32 on Precision Medicine and Oncology, and 44 on static and spatiotemporal genome analysis with NGS. These publications have received more than 8800 citations with h-index: 73 (Scopus). He is reviewer in many high impact journals including some with impact factor (IF) >30, evaluator in innovative research projects (EU, France, Belgium, Luxemburg, Poland), member in the editorial board of 25 international journals with IF, and Organizing Committee member in >20 International Conferences.
Chinese University of Hong Kong
George G Chen is a professor in the Department of Surgery, Director of Surgical Laboratories, Faculty of Medicine, Hong Kong, China. His research interest is the area of carcinogenesis, cancer treatment, early detection, and diagnosis. His study is focused on liver, lung and thyroid cancers. He has authored or co-authored more than 200 papers and has written a number of books or book chapters.
The Chinese University of Hong Kong (CUHK)
Prof. CHEN Yangcha is currently working as an Associate Professor at School of Biomedical Sciences, The Chinese University of Hong Kong (CUHK). He obtained his Ph.D. from Sun Yat-sen University. He trained as a postdoctoral fellow at University of Washington, Seattle. He has been faculty member as Research Assistant Professor, Assistant Professor and Associate Professor at Faculty of Medicine CUHK since 2007. His research interests include epigenetics in cancer, histone modification particularly methylation, long and short non-coding RNAs, development of novel therapeutics for liver and pancreatic cancer. The ultimate goal of his lab is aimed at the identification of novel diagnostic markers and therapeutic targets for pancreatic and liver cancer.